Stanford-StartX Fund-backed Inflammatix received series C funding led by Grey Sky ahead of the European release of its acute infection diagnostics platform.

The cancer antibody drug conjugate developer secured the return of Boehringer Ingelheim Venture Fund ahead of early clinical trials on its lead candidate.

Lowe's-backed home improvement services portal Porch has raised $20.6m of a targeted $37m according to a regulatory filing.

Cox Enterprises joined returning investors Hearst and Heritage Group in the medical payment service provider’s latest round, which took its overall funding to more than $50m.

The medical data analytics platform has raised $5m from Merck Global Health Innovation Fund, adding to $23m raised last year.

The colectomy-focused robotic surgical device developer has now assembled $51.7m having spun out from University of Nebraska Medical Center in 2006.

Inserm Transfer Initiative featured in the first round for VectivBio, a short bowel syndrome treatment developer spun out of Therachon following the latter's acquisition by Pfizer.

Novo took part in the first round for VectivBio, a short bowel syndrome treatment developer launched out of genetic disease drug developer Therachon.

The colectomy-focused surgical device developer, which counts SinoPharm as an earlier investor, has secured series B-plus funding, in a round led by Bluestem Capital.

The eye disease drug developer has closed a round led by existing backer Boehringer Ingelheim Venture Fund to take its total funding above $42m.